+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Microfluidic Immunoassay System Market - Global Forecast 2026-2032- Product Image
Microfluidic Immunoassay System Market - Global Forecast 2026-2032- Product Image
Sale

Microfluidic Immunoassay System Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283360
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Microfluidic Immunoassay Systems: Executive Summary

Microfluidic immunoassay systems combine miniaturized fluid handling with antibody- or antigen-based detection to support rapid, decentralized, and resource-efficient testing. Their value proposition centers on reduced sample and reagent use, shorter workflows, portability, and potential integration with digital readers. Adoption is shaped by analytical performance, workflow simplicity, regulatory requirements, reimbursement, laboratory infrastructure, and the availability of validated assays for clinically relevant applications.

Miniaturization, Decentralized Testing, and Workflow Integration Are Reshaping Adoption

The landscape is shifting from centralized, instrument-intensive testing toward more distributed diagnostic workflows. Point-of-care use, near-patient testing, multiplexing, automation, and connectivity are increasing the importance of systems that can deliver reproducible results outside conventional laboratories. At the same time, buyers are placing greater emphasis on quality control, contamination management, operator training, interoperability, and evidence demonstrating clinical utility rather than technical novelty alone.

Artificial Intelligence Is Strengthening Interpretation, Operations, and Quality Assurance

Artificial intelligence can enhance microfluidic immunoassay workflows by supporting image interpretation, signal classification, anomaly detection, calibration monitoring, and automated quality checks. Connected systems may also use machine learning to identify workflow deviations and improve maintenance planning. However, dependable deployment requires representative validation data, transparent performance criteria, cybersecurity safeguards, human oversight, and compliance with applicable medical-device and laboratory regulations. AI should augment validated assay processes, not substitute for analytical and clinical verification.

Regional Insights: Infrastructure and Regulatory Readiness Create Distinct Adoption Paths

North America benefits from established diagnostic infrastructure, strong demand for decentralized testing, and active investment in connected health technologies. Europe emphasizes analytical validation, data governance, sustainability, and harmonized but demanding regulatory pathways. Asia-Pacific combines advanced technology ecosystems in several economies with substantial unmet diagnostic-access needs, creating opportunities for scalable and rugged platforms. Latin America is influenced by uneven laboratory capacity, procurement constraints, and the need for cost-conscious decentralization. The Middle East is supported by healthcare modernization and centralized investment, while implementation depends on local validation and workforce readiness. Africa presents significant access needs and diverse infrastructure conditions, favoring portable systems with simple operation, dependable supply chains, and strong external quality assurance.

Group Insights: Economic and Institutional Blocs Shape Procurement Priorities

ASEAN markets tend to prioritize adaptable, affordable solutions that can operate across varied healthcare settings and regulatory environments. BRICS members reflect diverse combinations of domestic manufacturing goals, public-sector procurement, and diagnostic-access priorities. The European Union places strong weight on conformity, traceability, data protection, and cross-border evidence requirements. G7 systems generally emphasize clinical validation, workflow integration, cybersecurity, and total cost of ownership. GCC countries often combine centralized purchasing with rapid healthcare infrastructure development, making implementation capability important. NATO members may additionally value resilient supply chains, interoperability, and continuity of essential diagnostic services.

Country Insights: Local Health Systems Determine Practical Deployment

Australia and Canada have geographically dispersed populations, increasing the relevance of decentralized testing and robust logistics. Brazil, Mexico, and India may benefit from platforms designed for varied laboratory capacity, affordability, and scalable public-health deployment. China, Japan, and South Korea have strong technology and manufacturing capabilities, while adoption still depends on clinical validation, regulatory alignment, and integration with established diagnostic pathways. France, Germany, Italy, and Spain place importance on evidence, quality systems, procurement processes, and integration with European requirements. The United Kingdom emphasizes validated clinical utility, system efficiency, and digital connectivity. The United States remains attentive to regulatory evidence, reimbursement considerations, laboratory workflow integration, and cybersecurity. Russia’s deployment context is shaped by domestic supply considerations, infrastructure variation, and applicable national requirements.

Industry Leaders Should Prioritize Validated Utility, Interoperability, and Resilience

Leaders should focus product development on clearly defined clinical and operational use cases rather than broad claims. Build evidence packages that address analytical performance, clinical concordance, usability, environmental robustness, and health-economic value. Design modular platforms that support multiplex assays, secure connectivity, standardized data exchange, and straightforward quality control. Segment implementation plans by infrastructure maturity, and establish local training, service, reagent, and regulatory capabilities before scaling. Strengthen supply-chain resilience through qualified sourcing and inventory planning, while applying privacy-by-design, cybersecurity controls, and documented human oversight to AI-enabled functions.

Research Methodology: Evidence-Led Analysis of Technology and Adoption Conditions

This executive summary uses a structured assessment of the microfluidic immunoassay system category, examining technology characteristics, workflow requirements, diagnostic settings, regulatory considerations, infrastructure conditions, and regional or institutional differences. Insights are framed qualitatively and avoid unsupported estimates or forecasts. The analysis distinguishes technical potential from practical adoption by considering validation needs, procurement behavior, operator requirements, connectivity, quality assurance, and supply-chain readiness across the specified regions, groups, and countries.

Conclusion: Scalable Diagnostic Value Depends on Evidence and Execution

Microfluidic immunoassay systems are positioned to support faster, smaller-footprint, and more distributed testing, but successful adoption will depend on more than miniaturization. Strong analytical evidence, intuitive workflows, dependable consumables, regulatory discipline, interoperability, and service support will determine practical value. Artificial intelligence can extend system capabilities when governed responsibly. Organizations that align platform design with local infrastructure, clinical priorities, and resilient implementation models will be better placed to translate the technology into dependable diagnostic impact.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Microfluidic Immunoassay System Market, by System Type
7.1. Introduction
7.2. Lab-On-Chip
7.3. Cartridge-Based
7.4. Portable / Handheld
8. Microfluidic Immunoassay System Market, by Detection Technology
8.1. Introduction
8.2. Fluorescence-Based
8.3. Colorimetric
8.4. Electrochemical
8.5. Chemiluminescence
9. Microfluidic Immunoassay System Market, by Assay Format
9.1. Introduction
9.2. Single-Analyte
9.3. Multiplexed
10. Microfluidic Immunoassay System Market, by Sample Type
10.1. Introduction
10.2. Blood
10.3. Serum / Plasma
10.4. Urine
10.5. Saliva
11. Microfluidic Immunoassay System Market, by Application
11.1. Introduction
11.2. Point-of-Care Diagnostics
11.3. Clinical Laboratory Testing
11.4. Research & Development
11.5. Drug Discovery
12. Microfluidic Immunoassay System Market, by End-User
12.1. Introduction
12.2. Hospitals
12.3. Diagnostic Laboratories
12.4. Research Institutes
12.5. Pharmaceutical & Biotech Companies
13. Microfluidic Immunoassay System Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Microfluidic Immunoassay System Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Microfluidic Immunoassay System Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Agilent Technologies Inc.
17.3. Becton Dickinson and Company
17.4. Biosurfit SA
17.5. Bio-Rad Laboratories Inc.
17.6. Danaher Corporation
17.7. Dolomite Microfluidics Ltd.
17.8. Illumina Inc.
17.9. Koninklijke Philips N.V.
17.10. Merck KGaA
17.11. Meso Scale Diagnostics LLC
17.12. Micronit Microtechnologies BV
17.13. Micropoint Biotechnologies Co. Ltd.
17.14. NanoEnTek Inc.
17.15. Nanomix Corporation
17.16. PerkinElmer Inc.
17.17. QIAGEN N.V.
17.18. QuidelOrtho Corporation
17.19. Randox Laboratories Ltd.
17.20. Revvity Inc.
17.21. Roche Diagnostics International AG
17.22. Siemens Healthineers AG
17.23. Thermo Fisher Scientific Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Microfluidic Immunoassay System Market, Years Considered for the Study
FIGURE 2. Global Microfluidic Immunoassay System Market, Research Design
FIGURE 3. Global Microfluidic Immunoassay System Market, Research Framework
FIGURE 4. Global Microfluidic Immunoassay System Market, Data Triangulation
FIGURE 5. Global Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Microfluidic Immunoassay System Market Size, by System Type, 2025 vs 2032 (%)
FIGURE 7. Global Microfluidic Immunoassay System Market Size, by System Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Microfluidic Immunoassay System Market Size, by Detection Technology, 2025 vs 2032 (%)
FIGURE 9. Global Microfluidic Immunoassay System Market Size, by Detection Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Microfluidic Immunoassay System Market Size, by Assay Format, 2025 vs 2032 (%)
FIGURE 11. Global Microfluidic Immunoassay System Market Size, by Assay Format, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Microfluidic Immunoassay System Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 13. Global Microfluidic Immunoassay System Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Microfluidic Immunoassay System Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Microfluidic Immunoassay System Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Microfluidic Immunoassay System Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 17. Global Microfluidic Immunoassay System Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Microfluidic Immunoassay System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Microfluidic Immunoassay System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Microfluidic Immunoassay System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Microfluidic Immunoassay System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Microfluidic Immunoassay System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Microfluidic Immunoassay System Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Microfluidic Immunoassay System Market Segmentation & Coverage
TABLE 2. Global Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 4. Global Lab-On-Chip Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Lab-On-Chip Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Lab-On-Chip Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Cartridge-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Cartridge-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Cartridge-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Portable / Handheld Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Portable / Handheld Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Portable / Handheld Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 14. Global Fluorescence-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Fluorescence-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Fluorescence-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Colorimetric Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Colorimetric Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Colorimetric Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Electrochemical Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Electrochemical Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Electrochemical Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Chemiluminescence Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Chemiluminescence Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Chemiluminescence Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 27. Global Single-Analyte Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Single-Analyte Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Single-Analyte Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Multiplexed Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Multiplexed Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Multiplexed Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 34. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Serum / Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Serum / Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Serum / Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 47. Global Point-of-Care Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Point-of-Care Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Point-of-Care Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Clinical Laboratory Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Clinical Laboratory Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Clinical Laboratory Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Research & Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Research & Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Research & Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 60. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Pharmaceutical & Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Pharmaceutical & Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Pharmaceutical & Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Microfluidic Immunoassay System Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Microfluidic Immunoassay System Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 80. North America Microfluidic Immunoassay System Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. North America Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 82. North America Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 83. North America Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 84. North America Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 85. North America Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 86. North America Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 87. Latin America Microfluidic Immunoassay System Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Latin America Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 89. Latin America Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 90. Latin America Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 91. Latin America Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 92. Latin America Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 93. Latin America Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 94. Europe Microfluidic Immunoassay System Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Europe Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 96. Europe Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 97. Europe Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 98. Europe Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 99. Europe Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. Europe Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 101. Middle East Microfluidic Immunoassay System Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Middle East Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 103. Middle East Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 104. Middle East Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 105. Middle East Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 106. Middle East Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. Middle East Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 108. Africa Microfluidic Immunoassay System Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Africa Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 110. Africa Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 111. Africa Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 112. Africa Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 113. Africa Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. Africa Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 115. Global Microfluidic Immunoassay System Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. ASEAN Microfluidic Immunoassay System Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. ASEAN Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 118. ASEAN Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 119. ASEAN Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 120. ASEAN Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 121. ASEAN Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. ASEAN Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 123. GCC Microfluidic Immunoassay System Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. GCC Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 125. GCC Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 126. GCC Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 127. GCC Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 128. GCC Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. GCC Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 130. European Union Microfluidic Immunoassay System Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. European Union Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 132. European Union Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 133. European Union Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 134. European Union Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 135. European Union Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. European Union Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 137. BRICS Microfluidic Immunoassay System Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. BRICS Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 139. BRICS Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 140. BRICS Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 141. BRICS Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 142. BRICS Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. BRICS Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 144. G7 Microfluidic Immunoassay System Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. G7 Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 146. G7 Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 147. G7 Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 148. G7 Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 149. G7 Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. G7 Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 151. NATO Microfluidic Immunoassay System Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. NATO Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 153. NATO Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 154. NATO Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 155. NATO Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 156. NATO Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. NATO Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 158. Global Microfluidic Immunoassay System Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. United States Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 160. United States Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 161. United States Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 162. United States Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 163. United States Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 164. United States Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. United States Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 166. Canada Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 167. Canada Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 168. Canada Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 169. Canada Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 170. Canada Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 171. Canada Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Canada Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 173. Mexico Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 174. Mexico Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 175. Mexico Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 176. Mexico Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 177. Mexico Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 178. Mexico Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. Mexico Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 180. Brazil Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 181. Brazil Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 182. Brazil Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 183. Brazil Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 184. Brazil Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 185. Brazil Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Brazil Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 187. United Kingdom Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 188. United Kingdom Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 189. United Kingdom Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 190. United Kingdom Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 191. United Kingdom Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 192. United Kingdom Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. United Kingdom Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 194. Germany Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 195. Germany Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 196. Germany Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 197. Germany Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 198. Germany Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 199. Germany Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. Germany Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 201. France Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 202. France Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 203. France Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 204. France Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 205. France Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 206. France Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 207. France Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 208. Russia Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 209. Russia Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 210. Russia Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 211. Russia Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 212. Russia Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 213. Russia Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. Russia Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 215. Italy Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 216. Italy Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 217. Italy Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 218. Italy Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 219. Italy Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 220. Italy Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. Italy Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 222. Spain Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 223. Spain Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 224. Spain Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 225. Spain Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 226. Spain Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 227. Spain Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. Spain Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 229. China Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 230. China Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 231. China Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 232. China Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 233. China Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 234. China Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. China Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 236. India Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 237. India Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 238. India Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 239. India Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 240. India Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 241. India Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. India Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 243. Japan Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 244. Japan Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 245. Japan Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 246. Japan Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 247. Japan Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 248. Japan Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. Japan Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 250. Australia Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 251. Australia Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 252. Australia Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 253. Australia Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 254. Australia Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 255. Australia Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. Australia Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 257. South Korea Microfluidic Immunoassay System Market Size, 2017-2032 (USD Million)
TABLE 258. South Korea Microfluidic Immunoassay System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 259. South Korea Microfluidic Immunoassay System Market Size, by Detection Technology, 2017-2032 (USD Million)
TABLE 260. South Korea Microfluidic Immunoassay System Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 261. South Korea Microfluidic Immunoassay System Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 262. South Korea Microfluidic Immunoassay System Market Size, by Application, 2017-2032 (USD Million)
TABLE 263. South Korea Microfluidic Immunoassay System Market Size, by End-User, 2017-2032 (USD Million)
TABLE 264. Global Microfluidic Immunoassay System Market Share, by Key Player, 2025
TABLE 265. Global Microfluidic Immunoassay System Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton Dickinson and Company
  • Biosurfit SA
  • Bio‑Rad Laboratories Inc.
  • Danaher Corporation
  • Dolomite Microfluidics Ltd.
  • Illumina Inc.
  • Koninklijke Philips N.V.
  • Merck KGaA
  • Meso Scale Diagnostics LLC
  • Micronit Microtechnologies BV
  • Micropoint Biotechnologies Co. Ltd.
  • NanoEnTek Inc.
  • Nanomix Corporation
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Revvity Inc.
  • Roche Diagnostics International AG
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Portable Fluorescence Immunoassay Analyzer Market - Global Forecast 2026-2032 - Product Image

Portable Fluorescence Immunoassay Analyzer Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Polymer Microfluidic Chips for in Vitro Diagnostics Market - Global Forecast 2026-2032 - Product Image

Polymer Microfluidic Chips for in Vitro Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Microfluidic Immunoassay Market by Product, Technology, Application, and End User - Global Forecast to 2030 - Product Image

Microfluidic Immunoassay Market by Product, Technology, Application, and End User - Global Forecast to 2030

  • Report
  • 269 Pages
  • Global
From
Microfluidic Chip in Biomedical Field Market - Global Forecast 2026-2032 - Product Image

Microfluidic Chip in Biomedical Field Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Immunoassay Market - Global Forecast 2026-2032 - Product Image

Immunoassay Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.